Neuca

Neuca Net Change in Cash

The Net Change in Cash of Neuca (NEU.WA) as of Oct 22, 2026 is 28.13 M PLN. In the previous year, Net Change in Cash was 4.75 M PLN — a change of 492.79% (higher).

Net Change in Cash

28.13 MPLN

YoY

492.79%

Last updated:

Net Change in Cash of Neuca is 2025 28.13 M PLN. Net Change in Cash of Neuca was 2024 4.75 M PLN. It decreases by 492.79% higher compared to the previous year.

The Neuca Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2018
2.91 M PLN
Jan 1, 2019
46.31 M PLN
Jan 1, 2020
-56.31 M PLN
Jan 1, 2021
41.96 M PLN
Jan 1, 2022
143.85 M PLN
Jan 1, 2023
-103.38 M PLN
Jan 1, 2024
4.75 M PLN
Jan 1, 2025
28.13 M PLN
The Neuca Net Change in Cash history
YEARNet Change in CashYoY
28.13 MPLN+492.79%
4.75 MPLN-104.59%
-103.38 MPLN-171.86%
143.85 MPLN+242.88%
41.96 MPLN-174.51%
-56.31 MPLN-221.58%
46.31 MPLN+1,489.29%
2.91 MPLN-107.49%
-38.93 MPLN+983.80%
-3.59 MPLN-108.95%
40.11 MPLN+45.45%
27.58 MPLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neuca Stock analysis

What does Neuca do? NEUCA SA generates revenue through the wholesale distribution of pharmaceutical products to pharmacies, leveraging its extensive network in the health market. The company also produces and sells its own branded drugs, supplements, and cosmetics, while offering clinical trials, telemedicine services, and IT solutions tailored for healthcare providers. Its e-commerce platform further supports the healthcare industry by enabling digital transactions for medical products and services. The primary buyers include pharmacies, healthcare institutions, and consumers seeking health-related products through online channels. NEUCA SA's business model integrates multiple revenue streams within the health sector, with a focus on both physical and digital distribution. The firm's own-brand products, such as pharmaceuticals and cosmetics, are sold directly to end-users and retail partners, while its IT solutions and telemedicine services target healthcare organizations. Clinical trials represent another key segment, attracting partnerships with research institutions and pharmaceutical firms. The company's operational scope spans from production to distribution, ensuring a comprehensive approach to healthcare market needs. The company's revenue is driven by its diversified portfolio, including drug distribution, branded product sales, and specialized services like telemedicine and clinical trials. Pharmacies remain the core customer segment for its wholesale operations, while e-commerce and IT solutions cater to a broader audience of healthcare providers and consumers. NEUCA SA's strategic positioning in the health market allows it to capitalize on multiple growth areas without relying on a single revenue source. Neuca is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neuca stock

Net Change in Cash of Neuca is 28.13 M PLN in 2025.

Net Change in Cash of Neuca changed from 4.75 M PLN to 28.13 M PLN, representing a 492.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Neuca since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Neuca historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Neuca

All Key Metrics — Neuca